BioSpace News Archive

One of Time Magazine’s Golden Geeks of the Internet, Douglas Colbeth, thinks the Internet has only exacerbated mental health issues. However, he believes it can now be part of the solution to fix the current broken mental healthcare model.

Long-term studies of live cells are set to take a significant leap forward with the introduction of a motorized stage and custom-designed stitching software for Tomocube’s holotomography microscopes.

Clementia’s late-stage drug candidate, palovarotene, has rare pediatric disease and breakthrough therapy designations for the treatment of an ultra-rare bone disorder and a path to approval in 2020

Masimo announced the findings of a series of four clinical cases, recently published in the Canadian Journal of Anesthesiology, in which researchers at the University of Montreal found that combined use of Masimo SedLine® brain function monitoring and O3® regional oximetry assisted their understanding and management of cerebral desaturations during cardiac surgery.

Athletes are checking out SynTech Nutrition’s all-in-one pre-workout supplement.

The shareholders of BioInvent International AB Reg. No. 556537-7263, are hereby invited to attend the Extraordinary General Meeting (the “EGM”) to be held at 10:00 a.m., Wednesday 20 March 2019 at Elite Hotel Ideon, Scheelevägen 27 in Lund, Sweden.

Reon Revive is a sugar-free, zero-calorie alternative to energy drinks for staying energized on the go or giving you a boost in-between activities.

Coverage will now include Medicare in 38 states and 19 Blue Cross Blue Shield plans

SK Capital Partners, a private investment firm focused on the specialty materials, chemicals and pharmaceuticals sectors, announced the final close of SK Capital Partners Fund V with total committed capital of approximately $2.1 billion.

Collaboration with experts in photopheresis field expected to further enhance understanding of photopheresis’ effect on immune modulation across a range of severe and critical conditions